155 related articles for article (PubMed ID: 21516322)
1. Plasma free myristic acid proportion is a predictor of nonalcoholic steatohepatitis.
Tomita K; Teratani T; Yokoyama H; Suzuki T; Irie R; Ebinuma H; Saito H; Hokari R; Miura S; Hibi T
Dig Dis Sci; 2011 Oct; 56(10):3045-52. PubMed ID: 21516322
[TBL] [Abstract][Full Text] [Related]
2. Serum immunoglobulin a concentration is an independent predictor of liver fibrosis in nonalcoholic steatohepatitis before the cirrhotic stage.
Tomita K; Teratani T; Yokoyama H; Suzuki T; Irie R; Ebinuma H; Saito H; Hokari R; Miura S; Hibi T
Dig Dis Sci; 2011 Dec; 56(12):3648-54. PubMed ID: 21674175
[TBL] [Abstract][Full Text] [Related]
3. A Simple Index for Nonalcoholic Steatohepatitis-HUFA-Based on Routinely Performed Blood Tests.
Culafic M; Vezmar Kovacevic S; Dopsaj V; Stulic M; Vlaisavljevic Z; Miljkovic B; Culafic D
Medicina (Kaunas); 2019 Jun; 55(6):. PubMed ID: 31163711
[No Abstract] [Full Text] [Related]
4. Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines.
Jamali R; Arj A; Razavizade M; Aarabi MH
Medicine (Baltimore); 2016 Feb; 95(5):e2630. PubMed ID: 26844476
[TBL] [Abstract][Full Text] [Related]
5. Ketone body production is differentially altered in steatosis and non-alcoholic steatohepatitis in obese humans.
Männistö VT; Simonen M; Hyysalo J; Soininen P; Kangas AJ; Kaminska D; Matte AK; Venesmaa S; Käkelä P; Kärjä V; Arola J; Gylling H; Cederberg H; Kuusisto J; Laakso M; Yki-Järvinen H; Ala-Korpela M; Pihlajamäki J
Liver Int; 2015 Jul; 35(7):1853-61. PubMed ID: 25533197
[TBL] [Abstract][Full Text] [Related]
6. Plasma Pentraxin 3 Differentiates Nonalcoholic Steatohepatitis (NASH) from Non-NASH.
Boga S; Koksal AR; Alkim H; Yilmaz Ozguven MB; Bayram M; Ergun M; Sisman G; Tekin Neijmann S; Alkim C
Metab Syndr Relat Disord; 2015 Nov; 13(9):393-9. PubMed ID: 26367098
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound Fatty Liver Indicator: A Simple Tool for Differentiating Steatosis From Nonalcoholic Steatohepatitis: Validity in the Average Obese Population.
Nelson SM; Hoskins JD; Lisanti C; Chaudhuri J
J Ultrasound Med; 2020 Apr; 39(4):749-759. PubMed ID: 31647137
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of a combined evaluation of the serum adiponectin level, HOMA-IR, and serum type IV collagen 7S level to predict the early stage of nonalcoholic steatohepatitis.
Shimada M; Kawahara H; Ozaki K; Fukura M; Yano H; Tsuchishima M; Tsutsumi M; Takase S
Am J Gastroenterol; 2007 Sep; 102(9):1931-8. PubMed ID: 17511754
[TBL] [Abstract][Full Text] [Related]
9. Serum thioredoxin levels as a predictor of steatohepatitis in patients with nonalcoholic fatty liver disease.
Sumida Y; Nakashima T; Yoh T; Furutani M; Hirohama A; Kakisaka Y; Nakajima Y; Ishikawa H; Mitsuyoshi H; Okanoue T; Kashima K; Nakamura H; Yodoi J
J Hepatol; 2003 Jan; 38(1):32-8. PubMed ID: 12480557
[TBL] [Abstract][Full Text] [Related]
10. Is nonalcoholic steatohepatitis associated with a high-though-normal thyroid stimulating hormone level and lower cholesterol levels?
Carulli L; Ballestri S; Lonardo A; Lami F; Violi E; Losi L; Bonilauri L; Verrone AM; Odoardi MR; Scaglioni F; Bertolotti M; Loria P
Intern Emerg Med; 2013 Jun; 8(4):297-305. PubMed ID: 21559749
[TBL] [Abstract][Full Text] [Related]
11. Soluble forms of extracellular cytokeratin 18 may differentiate simple steatosis from nonalcoholic steatohepatitis.
Yilmaz Y; Dolar E; Ulukaya E; Akgoz S; Keskin M; Kiyici M; Aker S; Yilmaztepe A; Gurel S; Gulten M; Nak SG
World J Gastroenterol; 2007 Feb; 13(6):837-44. PubMed ID: 17352011
[TBL] [Abstract][Full Text] [Related]
12. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-induced liver injury in superobese patients with nonalcoholic steatohepatitis.
Bechmann LP; Kocabayoglu P; Sowa JP; Sydor S; Best J; Schlattjan M; Beilfuss A; Schmitt J; Hannivoort RA; Kilicarslan A; Rust C; Berr F; Tschopp O; Gerken G; Friedman SL; Geier A; Canbay A
Hepatology; 2013 Apr; 57(4):1394-406. PubMed ID: 23299969
[TBL] [Abstract][Full Text] [Related]
13. Fatty acid metabolism is altered in non-alcoholic steatohepatitis independent of obesity.
Walle P; Takkunen M; Männistö V; Vaittinen M; Lankinen M; Kärjä V; Käkelä P; Ågren J; Tiainen M; Schwab U; Kuusisto J; Laakso M; Pihlajamäki J
Metabolism; 2016 May; 65(5):655-666. PubMed ID: 27085774
[TBL] [Abstract][Full Text] [Related]
14. Altered DNA Methylation Sites in Peripheral Blood Leukocytes from Patients with Simple Steatosis and Nonalcoholic Steatohepatitis (NASH).
Wu J; Zhang R; Shen F; Yang R; Zhou D; Cao H; Chen G; Pan Q; Fan J
Med Sci Monit; 2018 Oct; 24():6946-6967. PubMed ID: 30270343
[TBL] [Abstract][Full Text] [Related]
15. Plasma Pentraxin3 is a novel marker for nonalcoholic steatohepatitis (NASH).
Yoneda M; Uchiyama T; Kato S; Endo H; Fujita K; Yoneda K; Mawatari H; Iida H; Takahashi H; Kirikoshi H; Inamori M; Nozaki Y; Kobayashi N; Kubota K; Saito S; Maeyama S; Sagara M; Aburatani H; Kodama T; Nakajima A
BMC Gastroenterol; 2008 Nov; 8():53. PubMed ID: 19014569
[TBL] [Abstract][Full Text] [Related]
16. Serum homocysteine levels in patients with nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Patsiaoura K; Katsiki E; Zafeiriadou E; Deretzi G; Zavos C; Gavalas E; Katsinelos P; Mane V; Slavakis A
Ann Hepatol; 2012; 11(1):68-76. PubMed ID: 22166563
[TBL] [Abstract][Full Text] [Related]
17. A simple clinical scoring system using ferritin, fasting insulin, and type IV collagen 7S for predicting steatohepatitis in nonalcoholic fatty liver disease.
Sumida Y; Yoneda M; Hyogo H; Yamaguchi K; Ono M; Fujii H; Eguchi Y; Suzuki Y; Imai S; Kanemasa K; Fujita K; Chayama K; Yasui K; Saibara T; Kawada N; Fujimoto K; Kohgo Y; Okanoue T;
J Gastroenterol; 2011 Feb; 46(2):257-68. PubMed ID: 20842510
[TBL] [Abstract][Full Text] [Related]
18. High-sensitivity C-reactive protein is an independent clinical feature of nonalcoholic steatohepatitis (NASH) and also of the severity of fibrosis in NASH.
Yoneda M; Mawatari H; Fujita K; Iida H; Yonemitsu K; Kato S; Takahashi H; Kirikoshi H; Inamori M; Nozaki Y; Abe Y; Kubota K; Saito S; Iwasaki T; Terauchi Y; Togo S; Maeyama S; Nakajima A
J Gastroenterol; 2007 Jul; 42(7):573-82. PubMed ID: 17653654
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography: can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?
Shigefuku R; Takahashi H; Kobayashi M; Ikeda H; Matsunaga K; Okuse C; Matsumoto N; Maeyama S; Sase S; Suzuki M; Itoh F
J Gastroenterol; 2012 Nov; 47(11):1238-47. PubMed ID: 22576023
[TBL] [Abstract][Full Text] [Related]
20. Use of non-invasive serum glycan markers to distinguish non-alcoholic steatohepatitis from simple steatosis.
Yamasaki Y; Nouso K; Miyahara K; Wada N; Dohi C; Morimoto Y; Kinugasa H; Takeuchi Y; Yasunaka T; Kuwaki K; Onishi H; Ikeda F; Miyake Y; Nakamura S; Shiraha H; Takaki A; Iwasaki Y; Amano M; Nishimura S; Yamamoto K
J Gastroenterol Hepatol; 2015 Mar; 30(3):528-34. PubMed ID: 25168691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
